StockTipsArenaBeta

Mankind Pharma Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹2,275.6-9.90 (-0.43%)

Avg 1-year target

7 of 9 long-term calls BUY

₹2,774.7121.9% above today's price

Mankind Pharma's average 1-year share price target is ₹2,774.71, the average of 7 advisors' latest targets. Targets range from ₹2,200 to ₹3,220.

Latest: Macquarie ₹2,200 · 7 Oct 2026

11
9 BUY · 2 SELL, all horizons
7
with an active 1Y target
22%
11 of 51 closed calls hit
63
all horizons, open and closed
Watch MANKIND for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Mankind Pharma target price by brokerage

Each advisor's latest 1-year target · 7 advisors · tap a row for the call

All tips (63)

SELLTarget₹2,200
MbyMacquarie+3.3% to target
1 Year* · 12 mo left · 7 Oct 2026 · entry ₹2,500.9 · via Zee Business (Live)P&L +9.0%
BUYTarget₹3,000
KSbyKotak Securities+31.8% to target
1 Year* · 11 mo left · 22 Sept 2026 · entry ₹2,450 · via NDTV Profit (Live)P&L -7.1%
BUYTarget₹2,600
GSbyGaurang Shah, Geojit Investments+14.3% to target
1 Year · 11 mo left · 11 Sept 2026 · entry ₹2,228.1 · via CNBC Awaaz.P&L +2.1%
BUYTarget₹2,616
ECbyElara Capital+15.0% to target
1 Year* · 10 mo left · 27 Aug 2026 · entry ₹2,418 · via Economic Times Stock Recos OverviewP&L -5.9%
BUYTarget₹3,220
JIbyJefferies India+41.5% to target
1 Year* · 10 mo left · 4 Aug 2026 · entry ₹2,474.9 · via Financial Express MarketP&L -8.1%
SELLTarget₹2,080
MbyMacquarie+8.6% to target
1 Year* · 9 mo left · 31 Jul 2026 · entry ₹2,604 · via CNBC Awaaz.P&L +12.6%
BUYTarget₹2,975
MObyMotilal Oswal+30.7% to target
1 Year* · 9 mo left · 31 Jul 2026 · entry ₹2,469.6 · via Moneycontrol Broker ResearchP&L -7.9%
BUYTarget₹3,000
JIbyJefferies India+31.8% to target
1 Year* · 9 mo left · 9 Jul 2026 · entry ₹2,503.3 · via Zee Business (Live)P&L -9.1%
BUYTarget₹2,812
IRbyIncred Research+23.6% to target
1 Year* · 9 mo left · 7 Jul 2026 · entry ₹2,526.5 · via CNBC Awaaz.P&L -9.9%
BUYTarget₹2,640
MObyMotilal OswalTarget hit
1 Year* · 29 Apr 2026 · entry ₹2,256.8 · via Institutional / Brokerage Researchexit ₹2,640
BUYTarget₹2,600
GFbyGeojit Financial ServicesTarget hit
1 Year* · 26 Nov 2025 · entry ₹2,258.9 · via Institutional / Brokerage Researchexit ₹2,600
BUYTarget₹2,760
MObyMotilal OswalTarget hit
1 Year* · 23 Aug 2024 · entry ₹2,362.45 · via Institutional / Brokerage Researchexit ₹2,760
BUYTarget₹2,650
MObyMotilal OswalTarget hit
1 Year* · 13 Jun 2024 · entry ₹2,240.2 · via Institutional / Brokerage Researchexit ₹2,650
BUYTarget₹2,990
MObyMotilal OswalExpired
1 Year* · 1 Aug 2025 · entry ₹2,566.3 · via Institutional / Brokerage Researchexit ₹2,469.6
BUYTarget₹2,910
MObyMotilal OswalExpired
1 Year* · 22 May 2025 · entry ₹2,439.2 · via Institutional / Brokerage Researchexit ₹2,479.4
BUYTarget₹3,050
MObyMotilal OswalExpired
1 Year* · 25 Jan 2025 · entry ₹2,465.45 · via Institutional / Brokerage Researchexit ₹2,107.6
BUYTarget₹3,140
MObyMotilal OswalExpired
1 Year* · 5 Nov 2024 · entry ₹2,714.25 · via Institutional / Brokerage Researchexit ₹2,369.5
BUYTarget₹2,650
SCbyShrikant Chouhan, Kotak Securities+16.5% to target
1–3 Months · 2 mo left · 29 Sept 2026 · entry ₹2,545 · via CNBC Awaaz.P&L -10.6%
BUYTarget₹2,650
NSbyNagaraj Shetty, HDFC Securities+16.5% to target
1–3 Months* · 2 mo left · 29 Sept 2026 · entry ₹2,545 · via ET NowP&L -10.6%
BUYTarget₹2,630
ICbyIDBI CapitalTarget hit
1–3 Months · 19 Jun 2026 · entry ₹2,425 · via IDBI Capital Research Calls Telegramexit ₹2,630
BUYTarget₹2,600
SMbySomil Mehta, SharekhanTarget hit
1–3 Months · 7 May 2026 · entry ₹2,381.8 · via CNBC Awaaz.exit ₹2,600
BUYTarget₹2,800
RVbyRaja VenkatramanStop-loss hit
1–3 Months · 30 Sept 2026 · entry ₹2,550 · via LiveMint Marketsexit ₹2,440
BUYTarget₹2,821
IRbyIncred ResearchExpired
1–3 Months* · 7 Jul 2026 · entry ₹2,541.5 · via NDTV Profit (Live)exit ₹2,500
BUYTarget₹2,800
SMbySomil Mehta, SharekhanExpired
1–3 Months · 6 Jul 2026 · entry ₹2,541.5 · via CNBC Awaaz.exit ₹2,500
BUYTarget₹2,600
SMbySomil Mehta, SharekhanTarget hit
1–2 Weeks* · 14 May 2026 · entry ₹2,462.9 · via CNBC Awaaz.exit ₹2,600
BUYTarget₹2,500
GSbyGaurav Sharma, Globe Capital MarketTarget hit
1–2 Weeks* · 6 May 2026 · entry ₹2,350 · via CNBC Awaaz.exit ₹2,500
BUYTarget₹2,640
VCbyVishvesh Chauhan, ChaseAlphaStop-loss hit
1–2 Weeks* · 30 Sept 2026 · entry ₹2,545 · via Zee Business (Live)exit ₹2,470
BUYTarget₹2,550
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 24 Sept 2026 · entry ₹2,488.3 · via CNBC Awaaz.exit ₹2,450
BUYTarget₹2,640
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
1–2 Weeks* · 24 Sept 2026 · entry ₹2,481 · via ET Now (Live)exit ₹2,425
BUYTarget₹2,550
MJbyManas JaiswalStop-loss hit
1–2 Weeks* · 22 Sept 2026 · entry ₹2,475.1 · via CNBC Awaaz.exit ₹2,449
BUYTarget₹2,800
SBbySumeet Bagadia, Choice BrokingStop-loss hit
1–2 Weeks* · 29 Jul 2026 · entry ₹2,618 · via LiveMint Buy-or-Sell (topic)exit ₹2,500
BUYTarget₹2,650
KPbyKunal Parar, Choice BrokingStop-loss hit
1–2 Weeks* · 28 Jul 2026 · entry ₹2,620 · via ET Nowexit ₹2,575
BUYTarget₹2,700
NJbyNilesh Jain, Centrum BrokingStop-loss hit
1–2 Weeks* · 28 Jul 2026 · entry ₹2,587.1 · via CNBC Awaaz.exit ₹2,550
BUYTarget₹2,690
SRbySahi ResearchStop-loss hit
1–2 Weeks* · 28 Jul 2026 · entry ₹2,574.5 · via Sahi Research Telegramexit ₹2,500
BUYTarget₹2,750
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 20 Jul 2026 · entry ₹2,571.7 · via Zee Business (Live)exit ₹2,450
BUYTarget₹2,700
LSbyLaxmikant Shukla, YES SecuritiesStop-loss hit
1–2 Weeks* · 15 Jul 2026 · entry ₹2,550 · via ET Nowexit ₹2,500
BUYTarget₹2,450
KJbyKavita Jain, Arihant Capital MarketsStop-loss hit
1–2 Weeks* · 10 Jun 2026 · entry ₹2,400 · via CNBC Awaaz.exit ₹2,360
BUYTarget₹2,450
PRbyPankaj RandadStop-loss hit
1–2 Weeks* · 4 Jun 2026 · entry ₹2,395 · via CNBC Awaaz.exit ₹2,375
BUYTarget₹2,600
PGbyPrakash GabaExpired
1–2 Weeks* · 22 Sept 2026 · entry ₹2,475.1 · via CNBC Awaaz.exit ₹2,500
BUYTarget₹2,450
ABbyAshish Bahety, Profitmart SecuritiesExpired
1–2 Weeks* · 2 Sept 2026 · entry ₹2,365.2 · via CNBC Awaaz.exit ₹2,246
BUYTarget₹2,750
JTbyJay Thakkar, ICICI SecuritiesExpired
1–2 Weeks* · 23 Jul 2026 · entry ₹2,558.8 · via Business Todayexit ₹2,435.6
BUYTarget₹2,655
ISbyICICI SecuritiesExpired
1–2 Weeks* · 6 Jul 2026 · entry ₹2,535 · via Economic Times New Stock Recosexit ₹2,480.8
BUYTarget₹2,460
MKbyMehul Kothari, Anand RathiExpired
1–2 Weeks* · 3 Jun 2026 · entry ₹2,355 · via Zee Business (Live)exit ₹2,359.2
BUYTarget₹2,525
MJbyManas JaiswalExpired
1–2 Weeks* · 29 May 2026 · entry ₹2,375.6 · via CNBC Awaaz.exit ₹2,371.4
BUYTarget₹2,700
CTbyChandan Taparia, Motilal OswalExpired
1–2 Weeks* · 20 May 2026 · entry ₹2,583.9 · via NDTV Profitexit ₹2,372.3
BUYTarget₹2,550
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
BTST · 7 Oct 2026 · entry ₹2,500 · via CNBC Awaaz.exit ₹2,470
BUYTarget₹2,660
MJbyManas JaiswalStop-loss hit
BTST · 28 Jul 2026 · entry ₹2,617.9 · via CNBC Awaaz.exit ₹2,600
BUYTarget₹2,650
PGbyPrakash GabaStop-loss hit
BTST · 28 Jul 2026 · entry ₹2,615.2 · via CNBC Awaaz.exit ₹2,600
BUYTarget₹2,600
JTbyJay Thakkar, ICICI SecuritiesStop-loss hit
BTST* · 30 Jun 2026 · entry ₹2,546.4 · via Zee Business (Live)exit ₹2,525
BUYTarget₹2,450
SCbyShrikant Chouhan, Kotak SecuritiesExpired
BTST · 18 Aug 2026 · entry ₹2,380 · via CNBC Awaaz.exit ₹2,390.9

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Full call history, all horizons: page 2 of 2

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks